Accuray provides cancer-care technology that uses robotics and image guidance to deliver precise, non-invasive radiation treatments. Its flagship CyberKnife system places a robotic arm around the patient to aim highly focused radiation beams at tumors anywhere in the body, performing radiosurgery without surgery. In 2011 it expanded its product line by acquiring TomoTherapy, adding a helical radiation therapy platform to its portfolio, broadening the ways clinicians can treat cancer. The company differentiates itself by combining robotics with real-time imaging to track tumors and adjust treatment in real time, and by offering a broader, multi-product radiation oncology system rather than a single device. Accuray’s goal is to provide effective, non-invasive cancer treatments to patients worldwide, growing its global installed base and advancing access to precise radiation therapy.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Madison, Wisconsin
Founded
1990
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?